Evidence map›Paper›PMID 30127349›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2018

Urinary sodium excretion and risk of cardiovascular disease in the Chinese population: a prospective study.

Huanhuan Liu, Xiangmin Gao, Long Zhou, Yong Wu, Ying Li, Jinzhuang Mai, Zhiqiang Nie, Yangfeng Wu, Xiaoqing Liu, Liancheng Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 5 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 5 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Quantitative verification of the effect of using an umami substance (L-glutamate) to reduce salt intake.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Article
  16. Umami and salt reduction.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Article
  17. Relationship of household salt intake level with long-term all-cause and cardiovascular disease mortality in Japan: NIPPON DATA80.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Article
  18. Practical and personal education of dietary therapy in hypertensive patients.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
  19. Article
  20. The optimal amount of salt intake.Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Huanhuan LiuDivision of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Xiangmin GaoDepartment of Epidemiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Long ZhouDivision of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Yong WuDepartment of Epidemiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ying LiDivision of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Jinzhuang MaiDepartment of Epidemiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhiqiang NieDepartment of Epidemiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Yangfeng WuPeking University Clinical Research Institute, Beijing, China.
Xiaoqing LiuDepartment of Epidemiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. drxqliu@21cn.com.
Liancheng ZhaoDivision of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China. zhaolch@163.com.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNGuangdong General Hospital · CNGuangdong Academy of Medical Sciences · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of dietary sodium (salt) on cardiovascular disease (CVD) has been debated for a long time. The present study aims to explore whether salt intake affects the risk of cardiovascular disease in the Chinese population. Data from a prospective cohort study that included 954 men and women aged 35-59 years at baseline from four urban and rural population samples in China were used. Each participant collected their overnight urine for three consecutive days during two seasons to estimate sodium intake. CVD events, including incidences of coronary heart disease (CHD), stroke, and death from CVD, and all-cause mortality were tested by Cox proportional hazards models. After a median of 18.6 years of follow-up, CVD events occurred in 81 (8.5%) participants, including 20 CHD and 64 stroke events. All-cause deaths occurred in 149 (15.6%) participants, including 31 CVD-related deaths, 56 cancer-related deaths and 62 other-cause deaths. The hazard ratios and 95% confidence intervals for CVD events in each of the sodium excretion tertiles were 1.00, 1.66 (0.79-3.47) and 3.04 (1.46-6.34), P for trend = 0.001. This trend was also found for stroke incidence (P for trend < 0.001). The cardiovascular mortality risk increased as the sodium excretion levels rose after adjusting for confounding factors (P for trend = 0.043). However, this trend was not significant after adjusting for the baseline systolic blood pressure and antihypertensive medication use (P for trend = 0.171). No significant associations were found between sodium excretion and all-cause, cancer-related or other-cause mortality. High urinary sodium excretion was independently associated with an increased risk of cardiovascular disease in the general Chinese population.

Indexed as

AdultBlood PressureCardiovascular DiseasesChinaFemaleHumansIncidenceMaleMiddle AgedProspective StudiesRiskSodiumSurvival RateSodium

Identifiers

PMID30127349
OpenAlexW2885076167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.